274 related articles for article (PubMed ID: 17482266)
1. The L-arginine paradox: Importance of the L-arginine/asymmetrical dimethylarginine ratio.
Bode-Böger SM; Scalera F; Ignarro LJ
Pharmacol Ther; 2007 Jun; 114(3):295-306. PubMed ID: 17482266
[TBL] [Abstract][Full Text] [Related]
2. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
Yamagishi S; Ueda S; Okuda S
Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
[TBL] [Abstract][Full Text] [Related]
3. [Asymmetric dimethylarginine: metabolism, arginine paradox, pathophysiology].
Gilinskiĭ MA
Usp Fiziol Nauk; 2007; 38(3):21-39. PubMed ID: 17977229
[TBL] [Abstract][Full Text] [Related]
4. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor.
Böger RH
J Nutr; 2004 Oct; 134(10 Suppl):2842S-2847S; discussion 2853S. PubMed ID: 15465797
[TBL] [Abstract][Full Text] [Related]
5. [Influence of L-arginine on development of atherosclerosis: what is the therapeutically assured?].
Bode-Böger SM
Dtsch Med Wochenschr; 2005 Mar; 130(11):593-8. PubMed ID: 15761791
[TBL] [Abstract][Full Text] [Related]
6. L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
Böger RH
Curr Opin Clin Nutr Metab Care; 2008 Jan; 11(1):55-61. PubMed ID: 18090660
[TBL] [Abstract][Full Text] [Related]
7. L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?
Siasos G; Tousoulis D; Antoniades C; Stefanadi E; Stefanadis C
Int J Cardiol; 2007 Apr; 116(3):300-8. PubMed ID: 16860889
[TBL] [Abstract][Full Text] [Related]
8. [Arginine and statins: relationship between the nitric oxide pathway and the atherosclerosis development].
Rasmusen C; Cynober L; Couderc R
Ann Biol Clin (Paris); 2005; 63(5):443-55. PubMed ID: 16230278
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of kaempferol against endothelial damage by an improvement in nitric oxide production and a decrease in asymmetric dimethylarginine level.
Xiao HB; Jun-Fang ; Lu XY; Chen XJ; Chao-Tan ; Sun ZL
Eur J Pharmacol; 2009 Aug; 616(1-3):213-22. PubMed ID: 19549512
[TBL] [Abstract][Full Text] [Related]
10. Reduced L-arginine level and decreased placental eNOS activity in preeclampsia.
Kim YJ; Park HS; Lee HY; Ha EH; Suh SH; Oh SK; Yoo HS
Placenta; 2006; 27(4-5):438-44. PubMed ID: 16009421
[TBL] [Abstract][Full Text] [Related]
11. Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney disease.
Ueda S; Yamagishi S; Kaida Y; Okuda S
Nephrology (Carlton); 2007 Dec; 12(6):582-90. PubMed ID: 17995585
[TBL] [Abstract][Full Text] [Related]
12. Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance.
Toutouzas K; Riga M; Stefanadi E; Stefanadis C
Horm Metab Res; 2008 Sep; 40(9):655-9. PubMed ID: 18792879
[TBL] [Abstract][Full Text] [Related]
13. The pharmacodynamics of L-arginine.
Böger RH
Altern Ther Health Med; 2014; 20(3):48-54. PubMed ID: 24755570
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric dimethylarginine--mechanisms and targets for therapeutic management.
Vladimirova-Kitova LG
Folia Med (Plovdiv); 2008; 50(1):12-21. PubMed ID: 18543783
[TBL] [Abstract][Full Text] [Related]
15. L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.
Böger RH; Ron ES
Altern Med Rev; 2005 Mar; 10(1):14-23. PubMed ID: 15771559
[TBL] [Abstract][Full Text] [Related]
16. Modulatory role of asymmetric dimethylarginine (ADMA) in cannabinoid tolerance and dependence.
Ulugol A
Med Hypotheses; 2009 Aug; 73(2):213-4. PubMed ID: 19329260
[TBL] [Abstract][Full Text] [Related]
17. The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function.
Richir MC; Bouwman RH; Teerlink T; Siroen MP; de Vries TP; van Leeuwen PA
JPEN J Parenter Enteral Nutr; 2008; 32(6):613-21. PubMed ID: 18974239
[TBL] [Abstract][Full Text] [Related]
18. Oral L-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass.
Lucotti P; Monti L; Setola E; La Canna G; Castiglioni A; Rossodivita A; Pala MG; Formica F; Paolini G; Catapano AL; Bosi E; Alfieri O; Piatti P
Metabolism; 2009 Sep; 58(9):1270-6. PubMed ID: 19592054
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide and the endothelium: history and impact on cardiovascular disease.
Yetik-Anacak G; Catravas JD
Vascul Pharmacol; 2006 Nov; 45(5):268-76. PubMed ID: 17052961
[TBL] [Abstract][Full Text] [Related]
20. Dimethylarginine dimethylaminohydrolase (DDAH)--a critical regulator of hypertensive left ventricular hypertrophy?
Bai Y; Hui R
Med Hypotheses; 2008; 70(5):962-6. PubMed ID: 17983707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
